Judith M. Matthews - 31 Mar 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Financial Officer
Signature
/s/ Judith M. Matthews
Issuer symbol
ITRM
Transactions as of
31 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Apr 2023, 20:00:18 UTC
Previous filing
14 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 31 Mar 2023 Ordinary Shares 100,000 $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.